Items where authors include "Baird, R.D."

Article

Baird, R.D., Bermejo de Las Heras, B., Ruiz-Borrego, M. et al. (20 more authors) (2025) Camizestrant in combination with three globally approved CDK4/6 inhibitors in women with ER+, HER2- advanced breast cancer: Results from SERENA-1. Clinical Cancer Research, 31 (20). pp. 4244-4254. ISSN 1078-0432

Hamilton, E., Oliveira, M., Turner, N. et al. (18 more authors) (2024) A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results. Annals of Oncology, 35 (8). pp. 707-717. ISSN 0923-7534

Ring, A. orcid.org/0000-0003-1230-2973, Kilburn, L.S. orcid.org/0000-0002-1987-7545, Pearson, A. orcid.org/0000-0002-5854-193X et al. (21 more authors) (2023) Olaparib and ceralasertib (AZD6738) in patients with triple-negative advanced breast cancer: Results from Cohort E of the plasmaMATCH trial (CRUK/15/010). Clinical Cancer Research, 29 (23). pp. 4751-4759. ISSN 1078-0432